Numerical Study of Impurity Effects on Quasiparticles within S-wave and Chiral P-wave Vortices

The impurity problems within vortex cores of two-dimensional s-wave and chiral p-wave superconductors are studied numerically in the framework of the quasiclassical theory of superconductivity and self-consistent Born approximation under a trial form of the pair potential. The dispersion and impurity scattering rate (the inverse of the relaxation time) of the Andreev bound state localized in vortex cores are deduced from the angular-resoloved local density of states. The energy dependence of the impurity scattering rates depends on the pairing symmetry; particularly, in the chiral p-wave vortex core where chirality and vorticity have opposite sign and hence the total angular momentum is zero, the impurities are ineffective and the scattering rate is vanishingly small. Owing to the cancellation of angular momentum between chirality and vorticity, the chiral p-wave vortex core is similar to locally realized s-wave region and therefore non-magnetic impurity is harmless as a consequence of Anderson's theorem. The results of the present study confirm the previous results of analytical study (J. Phys. Soc. Jpn. {\bf 69} (2000) 3378) in the Born limit.Comment: 8pages, 9figures, submitted to J. Phys. Soc. Jp

Aerosol Azacytidine Inhibits Orthotopic Lung Cancers in Mice through Its DNA Demethylation and Gene Reactivation Effects

We devised an aerosol based demethylation therapy to achieve therapeutic efficacy in premalignant or in situ lesions of lung cancer, without systemic toxicity. Optimum regimens of aerosolized azacytidine (Aza) were designed and used in orthotopic human non-small cell lung cancer xenograft models. The therapeutic efficacy and toxicity of aerosol Aza were compared with intravenously administered Aza. We observed that 80% of the droplets of the aerosol Aza measured ∼0.1-5 microns, which resulted in deposition in the lower bronchial airways. An animal model that phenocopies field carcinogeneisis in humans was developed by intratracheal inoculation of the human lung cancer cells in mice, thus resulting in their distribution throughout the entire airway space. Aerosolized Aza significantly prolonged the survival of mice bearing endo-bronchial lung tumors. The aerosol treatment did not cause any detectable lung toxicity or systemic toxicity. A pre-pharmacokinetic study in mice demonstrated that lung deposition of aerosolized Aza was significantly higher than the intravenous route. Lung tumors were resected after aerosol treatment and the methylation levels of 24 promoters of tumor-suppresser genes related to lung cancer were analyzed. Aerosol Aza significantly reduced the methylation level in 9 of these promoters and reexpressed several genes tested. In conclusion, aerosol Aza at non-cytotoxic doses appears to be effective and results in DNA demethylation and tumor suppressor gene re-expression. The therapeutic index of aerosol Aza is >100-fold higher than that of intravenous Aza. These results provide a preclinical rationale for a phase I clinical trial of aerosol Aza to be initiated at our Institution